Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010